Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_assertion type Assertion NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_head.
- NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_assertion description "[We determined the frequencies of three LPL polymorphisms (D9N, N291S, and S447X) in 899 men from the Veterans Affairs HDL Intervention Trial (VA-HIT), a study that examined the potential benefits of increasing HDL with gemfibrozil in men with established CHD and low high density lipoprotein cholesterol (HDL-C; < or =40 mg/dl), and compared them with those of men without CHD from the Framingham Offspring Study (FOS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_provenance.
- NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_assertion evidence source_evidence_literature NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_provenance.
- NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_assertion SIO_000772 15292370 NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_provenance.
- NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_assertion wasDerivedFrom befree-20140225 NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_provenance.
- NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_assertion wasGeneratedBy ECO_0000203 NP409241.RAonzx6zY7msJ1oeIExR_HS9Gw_7__dPKASzphaLJ5v_8130_provenance.